Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now full pipeline small index

Peri Implantitis: full-pipeline trial registry

2 of 5 indexed Peri Implantitis trials are currently recruiting.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 2 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Peri Implantitis: 5 US clinical trials tracked, 2 recruiting.

Peri Implantitis is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is OraPharma, running 1 of these trials.

Enrollment posture brief

Registry condition peri-implantitis

OPEN 2 | RECR 40% | LATE 1 | EARLY 1 | RANK #3391 | SPON 1

Nearest open-share peer: Achondroplasia (40% recruiting · 10 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Peri Implantitis (this)40%
Open-enrollment share among volume-matched conditions near Peri Implantitis

Peri Implantitis lists 2 open slots (40% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Peri Implantitis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Peri Implantitis is recruiting below its size-band peers.

    2 of 5 indexed trials (40%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Peri Implantitis research.

    OraPharma accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Most Peri Implantitis trials plan to enrol fewer than 100 people.

    Median target enrolment is 73 among the 5 trials that report a genuine target (sentinel values excluded). 3 of those (60%) plan for fewer than 100 participants.

  4. Peri Implantitis research is mostly interventional.

    4 interventional and 1 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 31

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 3 1

Named interventions

Most-linked intervention names on Peri Implantitis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Polyvinylsiloxane Device
1 trials
Synthetic Foam Device
1 trials
Polytetrafluoroethylene Tape Device
1 trials
Cotton Pellet Device
1 trials
Minocycline HCl Microspheres Drug
1 trials
Hydrogen Peroxide Drug
1 trials
Chlorhexidine Drug
1 trials
Simultaneous peri-implant debridement and regeneration Procedure
1 trials

US sites by state

Facility locations filed on Peri Implantitis trials. A trial with sites in several states counts in each.

Michigan 2 trials
Wisconsin 1 trials
Washington 1 trials
Virginia 1 trials
Tennessee 1 trials
South Carolina 1 trials
Pennsylvania 1 trials
New York 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Peri Implantitis page

5 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 2 Peri Implantitis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • OraPharma sponsors the most Peri Implantitis trials on record, review their full trial history before evaluating a specific study. See OraPharma's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Peri Implantitis condition card totals 5 registered trials; most-linked intervention Polyvinylsiloxane; top US site state Michigan. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.